NCT01323972
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- GSK Investigational Site Enugu, Nigeria
- GSK Investigational Site Jos, Nigeria
Clinical trial condition
Vector Borne Diseases
Explore clinical trials studying Vector Borne Diseases. Study availability and eligibility vary by location and protocol.
2,039 public trials
146 recruiting studies
Vector Borne Diseases trial results
NCT00436007
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- GSK Investigational Site Lambaréné, Gabon
- GSK Investigational Site Kintampo, Ghana
- GSK Investigational Site Dar es Salaam, Tanzania
NCT00935623
- Conditions
- Infections, Malaria, Malaria, Vivax, +5 more
- Locations
-
- WRAIR Clinical Trials Center Silver Spring, Maryland, United States
NCT01936766
- Conditions
- Acute Kidney Injury, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +17 more
- Locations
-
- Chittagong Medical College Hosiptal Chittagong, Bangladesh
NCT01231503
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- GSK Investigational Site Bangwe, Blantyre, Malawi
NCT02239614
- Conditions
- Arbovirus Infections, Dengue, Flaviviridae Infections, +7 more
- Locations
-
- Clinical Trials Center, Walter Reed Army Institute of Research (CTC, WRAIR) Silver Spring, Maryland, United States
NCT01710189
- Conditions
- Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
- Locations
-
- Surrey CRC, Egerton Road Guildford, Surrey, United Kingdom
Completed
Malaria Transmission Studies in Mali
NCT01829737
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Completed
Malaria in Early Life Study
NCT02001428
- Conditions
- Infections, Malaria, Malaria, Falciparum, +7 more
- Locations
-
- Timika Research Facility Timika, Special Region of Papua, Indonesia
Completed
Safety And Immunogenicity Of Novel Candidate Blood-Stage Malaria Vaccine P27A : Phase Ia/Ib
NCT01949909
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- CHUV CRC Lausanne, Switzerland
- Bagamoyo Clinical Trial Unit (BCTU) Bagamoyo, Tanzania